Market CloseCautious

Stocks Rise as Tech Gains Offset Mixed Economic Signals

Nasdaq led major indexes higher; Harley-Davidson jumped 10% on upgrade, Genmab rose 11% on trial data.

Money365.Market AI1 min readFear & Greed: 71 (Greed)

Where the market closed

S&P 500
7,773.95
▲ +0.66%
NASDAQ Composite
27,477.31
▲ +1.05%
DOW Jones
51,267.90
▲ +0.18%
Russell 2000
2,847.14
▲ +0.50%
FTSE 100
10,497.94
▲ +0.34%
VIX
15.55
▲ +1.57%
10Y Treasury Yield
5.30%
▲ +2 bps
Dollar Index
102.153
▲ +0.22%
EUR/USD
1.1223
▼ -0.30%
GBP/USD
1.3224
▼ -0.12%

Index levels, yields and exchange rates at the US close. Source: market data via Yahoo Finance. New to index investing? See our complete S&P 500 guide.

What moved the market

US equities advanced as technology shares lifted the Nasdaq 1.05%, driven by optimism around Meta's AI positioning and Nvidia's continued rally. Treasury yields rose modestly to 5.30% while the dollar strengthened, reflecting steady but cautious risk appetite.

The 30-second read

  • •S&P 500 gained 0.66%, Nasdaq up 1.05%, Dow added 0.18%
  • •Harley-Davidson rose 10% after Citi upgrade citing retail growth
  • •Genmab advanced 11% on positive cancer drug trial results
  • •10-year Treasury yield edged up to 5.30%, dollar index gained 0.22%
  • •Stock Fear & Greed index at 71/100, signaling caution in greedy territory

Today's top movers

GMAB▲ +11.0%Positive Phase 3 cancer drug trial data for epcoritamab

What to watch next

  • October 9 before openModerna joins Nasdaq-100
  • Pending federal approvalModern Treasury trust bank charter decision

Reference & disclosures

Sources & headlines

  • Modern Treasury seeks US trust bank charter for digital asset custody — Cointelegraph
  • If the Stock Market Crashes in 2026, I'm Making This 1 Investing Move Immediately — Yahoo
  • Sector Update: Tech Stocks Mixed Late Afternoon — Yahoo
  • The Simple Reason Meta and Google Will Win AI: Only “2% of US Households” Pay for It. — Yahoo
  • Could Nvidia reach a $6T market cap by the end of October? — Yahoo
  • Why I Think These Are the 2 Smartest Stocks to Buy With $5,000 in October — Yahoo
  • “Zuck Is the Winner” of the White House AI Accord, and Meta’s Open-Source Risk Just Shrank — Yahoo
  • MRNA Stock Soars Ahead Of Slated Return To Nasdaq-100; Retail Echoes Valuation Concerns — Yahoo
  • Genmab stock surges 11% on positive cancer drug trial data — Yahoo
  • Want Income for Life? Coca-Cola Has Raised Its Dividend for 64 Straight Years and Yields 2.5%. Here's Whether It Belongs in Your Portfolio. — Yahoo

Important Disclaimer — Not Investment Advice

Disclaimer: This article is provided by Money365.Market for general information and educational purposes only. It is not financial advice, a personal recommendation, or an inducement to buy, sell, or invest in any security or product. Capital is at risk and the value of investments can go down as well as up; past performance does not indicate future results. You should seek independent advice from an FCA-authorised adviser before making any financial decision.

Read the full disclaimer — 8 further points, including total-loss risk, our regulatory status and conflicts of interest

Nothing here is an offer or a solicitation to buy or sell anything, and reading it creates no advisory or fiduciary relationship between you and Money365.Market. Any decision you take is your own.

  • You can lose money — including all of it. Individual companies can and do fail, and some of the assets discussed can fall to zero. Only commit money you can afford to lose, and never borrow to invest on the strength of anything you read here.
  • Forecasts are opinion, not fact. Any valuation model, scenario, fair-value range, estimate or other forward-looking statement is illustrative, rests on assumptions that may prove wrong, and is never a price target, a forecast of actual outcomes, or a promise of any return.
  • Published at a point in time. Figures were believed accurate on the publication or last-updated date shown above and are not maintained afterwards; we are under no obligation to update them. Market and company data comes from third-party sources and is provided without warranty of accuracy, completeness or timeliness.
  • Automated content. This brief was compiled by an automated pipeline from validated news and market-data sources and passed through editorial and compliance checks. Automated content can still contain errors — verify anything you intend to rely on.
  • We are not regulated. Money365.Market is not authorised or regulated by the UK Financial Conduct Authority, is not registered with the U.S. Securities and Exchange Commission or FINRA as an investment adviser or broker-dealer, and is not a tax adviser. We hold no licence to give personal financial advice and do not do so.
  • Interests and independence. Money365.Market is not affiliated with, endorsed by or sponsored by any company, fund, exchange or platform mentioned, and is not paid to feature them. The author may hold positions in securities or assets discussed. The site earns revenue from advertising, subscriptions and, where labelled, affiliate links; this does not influence what we publish.
  • Your jurisdiction matters. Tax treatment, contribution limits, product availability and investor protections differ by country and can change. Speak to a qualified tax professional for tax matters, and to a locally licensed adviser if you are outside the UK.

Full terms: Disclaimer · Terms of Service · Privacy Policy